RESOURCES

Document Library

FORM

Requisition Form (Standard)

Tempus’ frontline order requisition form, without patient consent.
FORM

Patient Consent Form

Accompanying patient consent form to the frontline requisition form (only applicable in relevant states).
FORM

Requisition Form (NYS)

Tempus’ frontline order requisition form, New York State specific.
FORM

Patient Consent Form (NYS)

Accompanying patient consent form to the frontline requisition form (only applicable in New York State).
FORM

Patient Consent Form (International)

Tempus’ patient consent form for genomic testing, for international use.
FORM

Patient Consent Form (EU/UK)

Tempus’ patient consent form for genomic testing, for international use (EU/UK specific).
FORM

Requisition Form (International)

Tempus’ frontline order requisition form, for international use.
FORM

De-Identified Requisition Form (International)

A de-identified version of Tempus’ frontline order requisition form, for international use.
FORM

Requisition Form (EU-UK)

Tempus’ frontline order requisition form, for EU/UK use.
FORM

De-Identified Requisition Form (EU-UK)

A de-identified version of Tempus’ frontline order requisition form, for EU/UK use.
FORM

Requisition Form (xE)

Tempus’ whole exome DNA sequencing requisition form.
FORM

Hereditary Requisition Form (xG powered by Ambry Genetics®)

Tempus’ hereditary cancer requisition form.
FORM

Requisition Form (xG Supplement)

A form containing supplemental information required for Tempus’ xG Hereditary Cancer Panel.
FORM

Patient Consent Form (Spanish)

Formulario de consentimiento del paciente adjunto al formulario de solicitud principal (solo aplicable en los estados pertinentes).
FORM

Notice And Authorization for Health Records

Tempus’ notice and authorization for health records form.
FORM

Financial Assistance Form

Tempus’ financial assistance form.
FORM

Requisition Form (EU-Dutch)
FORM

Requisition Form (EU-French)
FORM

Requisition Form (EU-German)
FORM

Requisition Form (EU-Italian)
FORM

Requisition Form (EU-Spanish)
FORM

GeneDx xG Genetic Counseling Referral Form

Genetic Counseling Referral Form
FORM

GeneDx xG Genetic Counseling Patient Scheduling Information

Genetic Counseling Patient Scheduling Information
FORM

Ambry xG Genetic Counseling Referral Form

Genetic Counseling Referral Form
FORM

Ambry Cultured Fibroblasts Requisition

Cultured Fibroblasts Requisition
FORM

Hereditary Requisition Form (powered by GeneDX)
FORM

Requisition Form (PGx)

Tempus’ PGx order requisition form.
GUIDE

Requisition Form Guide

A guide designed to help you complete Tempus’ frontline requisition form.
GUIDE

Clinical Report Guide

A guide designed to help you understand Tempus’ clinical reports.
GUIDE

Clinical Report Sample

A sample version of Tempus’ clinical report.
GUIDE

Patient Information Guide

Tempus’s patient information brochure for oncology.
GUIDE

Lab Information Guide

An outline of Tempus’ state-of-the-art CAP-accredited and CLIA-certified sequencing lab equipment.
GUIDE

Specimen Guidelines for Oncology

Tempus’ specimen collection guidelines for providers.
GUIDE

Specimen Guidelines for Life Sciences

Tempus’ specimen collection guidelines for Life Sciences partners only.
GUIDE

Tempus nP Digital Patient Brochure (English)

Tempus’ patient information brochure for Neurology & Psychiatry.
GUIDE

Tempus nP Digital Patient Brochure (Spanish)

Folleto de información al paciente para los exámenes de Neurología y Psiquiatría de Tempus.
GUIDE

Tempus xG Overview

An overview of Tempus’ hereditary cancer panels.
GUIDE

Tempus xG Sample Report Guide

A guide designed to help you understand Tempus’ hereditary panels’ clinical reports.
GUIDE

Tempus NYS xF Clinical Overview

An overview of Tempus’ liquid biopsy assay for clinical audiences.
GUIDE

Medicare 14-Day Rule

Medicare's Laboratory Date of Service Policy, also known as the "14 day rule," determines whether Tempus bills Medicare or its hospital customers for laboratory tests provided to Medicare patients.
GUIDE

Germline Assay Guide (Ambry)

A guide to Tempus’ germline assay.
GUIDE

xG Indications for Testing Overview

Guidelines are developed to determine patients to consider for hereditary cancer testing.
GUIDE

HLA Genotyping Ambiguous Allele List (v2)

A list of the representative and associated ambiguous alleles reported by Tempus xT’s HLA genotyping feature.
GUIDE

Ambry xG Genetic Counseling Patient Guide

Genetic Counseling Patient Guide
GUIDE

Tempus OncoEMR Workflow Guide
GUIDE

IHC Offerings
GUIDE

Comprehensive Therapy Selection Overview

Detailed information regarding cancer type profiles in Comprehensive Therapy Selection orders.
GENE PANEL

Tempus xT Gene Panel (NYS)

A panel of genes detected by Tempus’ xT assay, New York State specific.
GENE PANEL

Tempus xF Gene Panel (NYS)

A panel of genes detected by Tempus’ xF assay, New York State specific.
GENE PANEL

Tempus xE Gene Panel

A panel of genes detected by Tempus’ xE assay.
VALIDATION

Tempus xT CDx Technical Information

Detailed information regarding the FDA approval of xT CDx.
VALIDATION

Tempus xT Validation

The combined latest validation summary for Tempus’ xT assay and a panel of genes detected by Tempus’ xT assay.
VALIDATION

Tempus xT Validation (NYS)

The latest validation summary for Tempus’ xT assay, New York State specific.
VALIDATION

Tempus xR Validation

The latest validation summary for Tempus’ xR assay.
VALIDATION

Tempus xF Validation

The latest combined validation summary for Tempus’ xF assay and a panel of genes detected by Tempus’ xF assay.
VALIDATION

Tempus xF Validation (NYS)

The latest validation summary for Tempus’ xF assay, New York State specific.
VALIDATION

Tempus DPYD Validation

The latest validation summary for Tempus' DPYD test.
VALIDATION

Tempus HRD Validation

The latest validation summary for Tempus' HRD test.
VALIDATION

Tempus TO Validation

The latest validation summary for Tempus' TO test.
VALIDATION

Tempus UGT1A1 Validation

The latest validation summary for Tempus' UGT1A1 test.
VALIDATION

Tempus xF+ Validation

The latest validation summary and panel of genes for Tempus’ xF+ assay.
VALIDATION

Tempus nP Validation Summary

The latest validation summary for Tempus’ nP PGx assay.
VALIDATION

Tempus xE Validation

The latest validation summary and panel of genes for Tempus’ xE assay.
VALIDATION

Tempus PurIST Validation

The latest validation summary for Tempus' PurIST test.
VALIDATION

Tempus IPS Validation

The latest validation summary for Tempus' IPS.
OTHER

CAP License (2023-2025)

Chicago, IL
OTHER

CLIA Certificate (2023-2025)

Chicago, IL
OTHER

CAP License (2023-2025)

Durham, NC
OTHER

CLIA Certificate (2023-2025)

Durham, NC
OTHER

CAP License (2023-2025)

Peachtree Corners, GA
OTHER

CLIA Certificate (2023-2025)

Peachtree Corners, GA
OTHER

CAP License (2021-2023)

Norcross, GA
OTHER

Identification of stage I/II melanoma patients at high risk for recurrence using a model combining clinicopathologic factors with gene expression profiling (CP-GEP)

Merlin
OTHER

Validation of a clinicopathological and gene expression profile model to identify patients with cutaneous melanoma where sentinel lymph node biopsy is unnecessary

Merlin
OTHER

Clinical evaluation of the clinicopathologic and gene expression profile (CP-GEP) in patients with melanoma eligible for sentinel lymph node biopsy: A multicenter prospective Dutch study

Merlin
OTHER

Validation of CP-GEP (Merlin Assay) for predicting sentinel lymph node metastasis in primary cutaneous melanoma patients: A U.S. cohort study

Merlin
OTHER

Identification of stage I/IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model

Merlin
OTHER

Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma

Merlin
OTHER

Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse

Merlin
OTHER

Pixel RAD EULA

This is data-driven precision medicine

This is the future of healthcare.